Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Moodys
Dow
Chinese Patent Office
Medtronic
Merck
Johnson and Johnson
Healthtrust
Boehringer Ingelheim

Generated: December 11, 2018

DrugPatentWatch Database Preview

Drug Price Trends for GABAPENTIN

« Back to Dashboard

Drug Price Trends for GABAPENTIN

Average Pharmacy Cost for GABAPENTIN

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
GABAPENTIN 800 MG TABLET 76282-0406-90 0.12366 EA 2018-11-21
GABAPENTIN 800 MG TABLET 76282-0406-05 0.12366 EA 2018-11-21
GABAPENTIN 800 MG TABLET 76282-0406-01 0.12366 EA 2018-11-21
Drug Name NDC Price/Unit ($) Unit Date

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Best Wholesale Price for GABAPENTIN

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
HORIZANT Arbor Pharmaceuticals, Inc. 53451-0101-01 30 215.24 7.17467 EA 2018-09-15 - 2023-09-14 Big4
HORIZANT Arbor Pharmaceuticals, Inc. 53451-0101-01 30 327.03 10.90100 EA 2018-09-15 - 2023-09-14 FSS
HORIZANT EXTENDED RELEASE 300MG TAB Arbor Pharmaceuticals, Inc. 53451-0103-01 30 215.24 7.17467 EA 2018-09-15 - 2023-09-14 Big4
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Cipla
Queensland Health
Teva
Baxter
Fish and Richardson
McKesson
AstraZeneca
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.